Editorial
Wei Wu, Tonglei Li, Ying Zheng. Editorial of Special Issue “The Biological Fate of Drug Nanocarriers”[J]. Acta Pharmaceutica Sinica B, 2021, 11(4): 850-851

Editorial of Special Issue “The Biological Fate of Drug Nanocarriers”
Wei Wua,b, Tonglei Lic, Ying Zhengd
a Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China;
b Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China;
c Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA;
d State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China
Abstract:
Key words:   
Received:     Revised:
DOI: 10.1016/j.apsb.2021.04.004
Corresponding author:     Email:
Author description:
Service
PDF(KB) Free
Print
0
Authors
Wei Wu
Tonglei Li
Ying Zheng

References:
1. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine:progress, challenges and opportunities. Nat Rev Canc 2017;17:20-37.
2. Zhao Z, Ukidve A, Krishnan V, Mitragotri S. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv Drug Deliv Rev 2019;143:3-21.
3. Hu X, Dong X, Lu Y, Qi J, Zhao W, Wu W. Bioimaging of nanoparticles:the crucial role of discriminating nanoparticles from free probes. Drug Discov Today 2017;22:382-7.
4. Wu W, Li T. Unraveling the in vivo fate and cellular pharmacokinetics of drug nanocarriers. Adv Drug Deliv Rev 2019;143:1-2.
5. Man F, Gawne PJ, T M de Rosales R. Nuclear imaging of liposomal drug delivery systems:a critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 2019;143:134-60.
6. Qi J, Hu X, Dong X, Lu Y, Lu H, Zhao W, et al. Towards more accurate bioimaging of drug nanocarriers:turning aggregationcaused quenching into a useful tool. Adv Drug Deliv Rev 2019; 143:206-25.
7. Chen T, He B, Tao J, He Y, Deng H, Wang X, et al. Application of Förster Resonance Energy Transfer (FRET) technique to elucidate intracellular and in vivo biofate of nanomedicines. Adv Drug Deliv Rev 2019;143:177-205.
8. Wang Y, Zhang Y, Wang J, Liang XJ. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems. Adv Drug Deliv Rev 2019;143:161-76.
9. Wang YC, Wang JJ, Zhu DD, Wang YF, Qing GC, Zhang YX, et al. Effect of physicochemical properties on in vivo fate of nanoparticle based cancer immunotherapies. Acta Pharm Sin B 2021;11:886-902.
10. Mazumdar S, Chitkara D, Mittal A. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers. Acta Pharm Sin B 2021;11:903-24.
11. de Oliveira Viana IM, Roussel S, Joan Defrêne, Lima EM, Barabé F, Bertrandn N. Innate and adaptive immunity responses toward nanomedicines. Acta Pharm Sin B 2021;11:852-70.
12. Yaghmur A, Mu H. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm Sin B 2021;11:871-85.
13. Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, et al. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B 2021;11:941-60.
14. Costa CP, Moreira JN, Sousa Lobo JM, Silva AC. In vivo fate of intranasal lipid-based nanocarriers:state of the art. Acta Pharm Sin B 2021;11:925-40.
15. Yang C, He B, Dai W, Zhang H, Zheng Y, Wang X, et al. The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems. Acta Pharm Sin B 2021;11:961-77.
16. Peng J, Xiao Y, Yang Q, Liu Q, Chen Y, Shi K, et al. Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy. Acta Pharm Sin B 2021;11:1069-82.
17. Martínez-López AL, González-Navarro CJ, Aranaz P, Vizmanos JL, Irache JM. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions. Acta Pharm Sin B 2021;11:989-1002.
18. Lin Z, Xi L, Chen S, Tao J, Wang Y, Chen X, et al. Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model. Acta Pharm Sin B 2021;11:1047-55.
19. Zhang J, Corpstein CD, Li T. Intracellular uptake of nanocrystals:probing with aggregation-induced emission of fluorescence and kinetic modeling. Acta Pharm Sin B 2021;11:1021-9.
20. Xia F, Chen ZJ, Zhu QG, Qi JP, Dong XC, Zhao WL, et al. Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route. Acta Pharm Sin B 2021;11:1010-20.
21. Yang Y, Lv Y, Shen C, Shi T, He H, Qi J, et al. In vivo dissolution of poorly water-soluble drugs:proof of concept based on fluorescence bioimaging. Acta Pharm Sin B 2021;11:1056-68.
22. Shen B, Shen C, Zhu W, Yuan H. Integral nanocrystals absorption exhibits high contribution to oral bioavailability enhancement of quercetin. Acta Pharm Sin B 2021;11:978-88.
23. Wang W, Huang Z, Li Y, Wang W, Shi J, Fu F, et al. Impact of particle size and pH on protein corona formation of solid lipid nanoparticles:a proof-of-concept study. Acta Pharm Sin B 2021;11:1030-46.
24. Meng XJ, Zhang Z, Tong J, Sun H, Fawcett JP, Gu JK. The biological fate of the polymer nanocarrier material, poly(ethylene glycol)-blockpoly(D,L-lactic acid), in rat. Acta Pharm Sin B 2021;11:1003-9.
Similar articles: